Patients with metastatic colorectal cancer who received frontline immune checkpoint inhibitor therapy had positive OS rates ...

"At Castle Biosciences, our commitment to advancing care for melanoma patients helps drive our continuous innovation," said Rebecca Critchley-Thorne, Ph.D., vice president, research and development, ...

Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced ...

ASI has announced the introduction of a new Pathology Tumor Detection model that could detect lymph node metastasis.

On the Q1 2025 earnings call, investors can expect updates regarding the progress in the development of CTMX's lead candidate ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Patients with metastatic HER2-positive breast cancer lived significantly longer without disease progression when they ...

A biotech firm based in Milton Park, Oxfordshire, has received a major boost after its T-cell therapy was awarded Breakthrough Therapy Designation by the US Food and Drug Administration, ...

Linda Jackson, who is living with stage 4 metastatic cancer, is running this year's London Marathon alongside her son David ...

In the Chinese mainland, toripalimab was the first domestic anti-PD-1 monoclonal antibody approved for marketing (approved in China as TUOYI ® ). Currently, there are twelve approved indications for ...

Investors will focus on lead drug Cabometyx’s performance when Exelixis EXEL reports first-quarter 2025 results shortly. The ...

Erasca continues developing novel RAS-pathway cancer drugs, backed by funding through 2027 and promising early results. Find ...